General Information About the Bloomington Deficiency Kit
Updated January 10, 2013
Stock Center logo

The Bloomington Deficiency Kit provides maximal coverage of the genome with the minimal number of deletions having molecularly mapped breakpoints. Regions not covered by molecularly defined deletions exist as gaps in coverage or they are deleted by cytologically defined deficiencies. Haplolethal and haplosterile loci (described in Marygold et al., 2007) are flanked as closely as possible with deletions as well as being covered by deletions when possible.

The molecularly defined deletions were generated primarily by the Bloomington Deletion Project, the DrosDel Project and Exelixis, Inc. from FRT-bearing transposable element insertions. Breakpoints have usually been mapped to single-base resolution. Other deletions have typically been characterized by polytene cytology and complementation tests with molecularly mapped mutations.

Arm
# of euchromatic genes
# undeleted euchromatic genes
% euchromatic coverage
Number of stocks
Download spreadsheet
1 2288 43 98.1 92 DK1
2L 2765 30 98.9 100 DK2L
2R 3089 54 98.3 89 DK2R
3L 2845 71 97.5 75 DK3L
3R 3535 40 98.9 103 DK3R
4 88 5 94.3 7 DK4
All 14610 243 98.3 466  
Recent Changes to the Kit
February 14, 2010
February 25, 2010
June 2, 2010
October 20, 2010
February 25, 2011
March 7, 2011
  • Added to DK2: 5330
  • Removed from DK2: 7790 (not as represented)
January 1, 2013
  • Removed from DK3: 8049 (lost stock, we are trying to replace it)